ArriVent BioPharma, Inc.
AVBP
$22.86
$0.050.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.12% | 4.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.32% | 13.96% | |||
| Operating Income | -1.32% | -13.96% | |||
| Income Before Tax | -3.48% | -10.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.48% | -10.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.48% | -10.68% | |||
| EBIT | -1.32% | -13.96% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -1.00% | 7.57% | |||
| Normalized Basic EPS | 0.82% | 6.96% | |||
| EPS Diluted | -1.00% | 7.57% | |||
| Normalized Diluted EPS | 0.82% | 6.96% | |||
| Average Basic Shares Outstanding | 2.46% | 19.73% | |||
| Average Diluted Shares Outstanding | 2.46% | 19.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||